← back to search

Peter J. Little

University of Science and Technology of China · CN
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Proteoglycans and glycosaminoglycans research, Protein Kinase Regulation and GTPase Signaling, TGF-β signaling in diseases, and Nitric Oxide and Endothelin Effects.
h-index
65
citations
13,784
works
354
NIH funding
primary concept
email

Recent publications

Hypertension Prevalence and Associated Risk Factors in a South African Population
International Journal of Environmental Research and Public Health 2026cited by 0position: contributordoi
HIV infection, antiretroviral therapy and vascular dysfunction: Effects, mechanisms and treatments.
2025cited by 11position: contributordoi
Endothelial Dysfunction Markers Correlate with the Time Since Completion of Tuberculosis Treatment and the Number of Previous Tuberculosis Episodes
Infectious Disease Reports 2025cited by 3position: contributordoi
Delineating the Significance of Several Inflammatory Markers in a Lung Tuberculosis Cohort During the Active and Post-Tuberculosis Stages of the Disease: An Observational Study in Cape Town, South Africa (2019 to 2024)
Infectious Disease Reports 2025cited by 1position: contributordoi
Multimorbidity Patterns and Functioning Associations Among Adults in a Local South African Setting: A Cross-Sectional Study
International Journal of Environmental Research and Public Health 2025cited by 1position: contributordoi
Metabolic Signatures and Diagnostic Prediction Models for Coronary Artery Disease and Type 2 Diabetes Mellitus: Insights From an Exploratory Study
iNew Medicine 2025cited by 0position: contributordoi
No Association Between AGT Gene Polymorphisms with Hypertension in a South African Population
Diabetes, Metabolic Syndrome and Obesity 2024cited by 4position: contributordoi
Retinal Vessel Functional Responses in South Africans Living With and Without HIV: The EndoAfrica‐NWU Study
Microcirculation 2024cited by 1position: contributordoi
The impact of mild COVID-19 on medium-term respiratory function.
2024cited by 1position: contributordoi
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
Pharmaceuticals 2023cited by 10position: contributordoi
Mouse models of atherosclerosis in translational research
Trends in Pharmacological Sciences 2022cited by 98position: middledoi
Kaempferol and atherosclerosis: From mechanism to medicine
Critical Reviews in Food Science and Nutrition 2022cited by 88position: middledoi
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
International Journal of Biological Sciences 2022cited by 81position: middledoi
Cardiovascular Profile of South African Adults with Low-Level Viremia during Antiretroviral Therapy.
2022cited by 7position: contributordoi
Cardiovascular effects of air pollution: current evidence from animal and human studies
American Journal of Physiology-Heart and Circulatory Physiology 2021cited by 110position: contributordoi
Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship
Biomedicines 2021cited by 78position: firstdoi
Physical Exercise Potentially Targets Epicardial Adipose Tissue to Reduce Cardiovascular Disease Risk in Patients with Metabolic Diseases: Oxidative Stress and Inflammation Emerge as Major Therapeutic Targets
Antioxidants 2021cited by 29position: contributordoi
Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study
Journal of Clinical Medicine 2021cited by 13position: contributordoi
HIV and Antiretroviral Therapy Are Independently Associated with Cardiometabolic Variables and Cardiac Electrical Activity in Adults from the Western Cape Region of South Africa
Journal of Clinical Medicine 2021cited by 6position: contributordoi
Mobility Deviations in Adults With Human Immunodeficiency Virus: A Cross-Sectional Assessment Using Gait Analysis, Functional Performance, and Self-Report
Open Forum Infectious Diseases 2021cited by 4position: contributordoi
Naringenin and naringin in cardiovascular disease prevention: A preclinical review
European Journal of Pharmacology 2020cited by 214position: middledoi
Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles
Arteriosclerosis Thrombosis and Vascular Biology 2020cited by 77position: middledoi
Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function
Frontiers in Pharmacology 2020cited by 56position: middledoi
HIV-related cardiovascular disease: any role for high-density lipoproteins?
American Journal of Physiology-Heart and Circulatory Physiology 2020cited by 14position: contributordoi
Targeting Mechanosensitive Transcription Factors in Atherosclerosis
Trends in Pharmacological Sciences 2019cited by 188position: middledoi
Hydrogels Based on Poly(aspartic acid): Synthesis and Applications
Frontiers in Chemistry 2019cited by 62position: middledoi
Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling
Cellular and Molecular Life Sciences 2019cited by 56position: lastdoi
Personal NO<sub>2</sub> and Volatile Organic Compounds Exposure Levels are Associated with Markers of Cardiovascular Risk in Women in the Cape Town Region of South Africa.
2019cited by 20position: contributordoi
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Pharmacology & Therapeutics 2018cited by 165position: middledoi
Endothelial function and dysfunction: Impact of metformin
Pharmacology & Therapeutics 2018cited by 122position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 18 papers (2019–2026)Suowen Xu · University of Science and Technology of China17 papers (2012–2022)Danielle Kamato · Griffith University8 papers (2013–2022)Patrick De Boever · Hasselt University6 papers (2019–2024)Nandu Goswami · Mbarara University of Science and Technology6 papers (2019–2024)Wenhua Zheng · University of Macau4 papers (2012–2014)Zhiping Liu · Shandong University3 papers (2012–2022)Haitao Wang · China South Industries Group (China)3 papers (2012–2017) · 3 papers (2012–2018)Frans Everson · Stellenbosch University3 papers (2019–2021)Peiqing Liu · General Administration of Quality Supervision, Inspection and Quarantine3 papers (2012–2013)Jianping Weng · University of Science and Technology of China3 papers (2022–2022)Narin Osman · Monash University3 papers (2013–2019)Neale Cohen · Baker Heart and Diabetes Institute2 papers (2014–2018)Shani Botha-Le Roux · North-West University2 papers (2022–2024)Merga B. Feyasa · Addis Ababa University2 papers (2025–2025)Samuel Alomatu · Colleges of Medicine of South Africa2 papers (2024–2026)Karina Berner · Publons2 papers (2021–2025)Olakunle Sanni · Ekiti State University2 papers (2025–2025)Jyoti Sharma · South African Medical Research Council2 papers (2024–2026)